全球心理健康市場規模、佔有率、成長分析、依年齡層（兒科、成人）、依服務（緊急心理健康服務、門診諮詢）- 2024-2031 年產業預測

Global Mental Health Market Size, Share, Growth Analysis, By Age Group(Pediatric, Adult), By Services(Emergency Mental Health Services, Outpatient Counseling) - Industry Forecast 2024-2031

出版日期: 2024年04月12日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球心理健康市場規模為3,996.1億美元，預計將從2023年的4,136.0億美元成長到2031年的5,446.3億美元，預測期內（2024-2031年）複合年成長率為3.5%。

全球心理健康市場涵蓋一系列旨在透過預防、治療和管理來解決心理健康障礙的產品和服務，包括藥物、心理治療、數位健康解決方案和其他治療介入。其使命是為那些面臨心理健康問題的人們提供有效且易於獲得的護理，旨在減輕他們對個人、家庭和社會的負擔。該市場的成長主要得益於全球精神健康疾病盛行率的不斷上升，人們對這些問題的認知和接受程度不斷提高，以及技術進步促進了數位健康解決方案等創新治療方式。然而，市場面臨著重大課題，特別是圍繞精神疾病的恥辱阻礙了尋求治療的行為，缺乏訓練有素的精神衛生專業人員，特別是在低收入和中等收入國家，以及不同文化和社會經濟之間治療效果的差異脈絡。此外，該行業還面臨著對心理健康計畫和服務的長期資金和支持不足的問題。儘管如此，成長和創新的機會依然存在，包括個人化和精準治療方法的潛力。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Pfizer Inc. (US)
Johnson & Johnson (US)
Eli Lilly and Company (US)
Bristol-Myers Squibb (US)
GlaxoSmithKline (UK)
AstraZeneca (UK)
Allergan plc (Ireland)
Merck & Co., Inc. (US)
Takeda Pharmaceutical Company Limited (Japan)
Otsuka Holdings Co., Ltd. (Japan)
Novartis International AG (Switzerland)
Sanofi SA (France)
Lundbeck A/S (Denmark)
Teva Pharmaceutical Industries Ltd. (Israel)
Mylan NV (Netherlands)
AbbVie Inc. (US)
Boehringer Ingelheim International GmbH (Germany)
H. Lundbeck A/S (Denmark)
Sun Pharmaceutical Industries Ltd. (India)
Alkermes plc (Ireland)

簡介目錄

Product Code: SQMIG35A2233

Global mental health market size was valued at USD 399.61 billion in 2022 and is poised to grow from USD 413.60 billion in 2023 to USD 544.63 billion by 2031, at a CAGR of 3.5% during the forecast period (2024-2031).

The global Mental Health market encompasses a spectrum of products and services aimed at addressing mental health disorders through prevention, treatment, and management, including pharmaceuticals, psychotherapy, digital health solutions, and other therapeutic interventions. Its mission is to offer effective and accessible care to those grappling with mental health issues, aiming to alleviate the burdens they impose on individuals, families, and society. The market's growth is primarily fueled by the escalating prevalence of mental health disorders worldwide, coupled with increasing awareness and acceptance of these issues, alongside technological advancements fostering innovative treatment modalities like digital health solutions. However, the market faces significant challenges, notably the stigma surrounding mental illness hindering treatment-seeking behavior, a shortage of trained mental health professionals, particularly in low and middle-income nations, and the variability of treatment effectiveness across different cultural and socio-economic contexts. Additionally, the sector grapples with inadequate long-term funding and support for mental health programs and services. Nevertheless, opportunities for growth and innovation persist, including the potential for personalized and precision-based treatment approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the global mental health market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mental Health Market Segmental Analysis

The global mental health market is segmented based on age group, services and region. By age group, the market is segmented into pediatric, adult, and geriatric. By services, the market is segmented into emergency mental health services, outpatient counseling, home-based treatment services, inpatient hospital treatment services, and other services. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Mental Health Market

The increasing prevalence of mental health disorders like depression, anxiety, and substance abuse serves as a significant catalyst for the global mental health market. This surge in mental health conditions has led to a heightened need for mental health services and treatments, consequently propelling the expansion of the market.

Restraints in the Global Mental Health Market

The restricted availability and accessibility of mental health services, especially in developing nations, pose a significant challenge for the global mental health market. This constraint limits the number of individuals able to access treatment for their mental health disorders, consequently constraining market growth.

Market Trends of the Global Mental Health Market

Telemedicine has become a prominent trend in the mental health sector. Through telemedicine, individuals can access remote mental health services like teletherapy and telepsychiatry using smartphones or computers from any location. This approach enhances accessibility and convenience for patients, especially those residing in rural or remote areas, and can also offer cost-effective solutions. Notable companies offering telemedicine services in the mental health sector include Teladoc Health and Amwell.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Mental Health Market by Age Group

Market Overview
Pediatric
Adult
and Geriatric

Global Mental Health Market by Services

Market Overview
Emergency Mental Health Services
Outpatient Counseling
Home-based Treatment Services
Inpatient Hospital Treatment Services
and Other Services

Global Mental Health Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Holdings Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lundbeck A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
H. Lundbeck A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alkermes plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments